抗体

• Charles River Laboratories Acquires Distributed Bio 2021-01-04
• 首发| 天辰生物完成超亿元A轮融资，专注自免疾病抗体新药研发 2021-01-04
• 誉衡生物即将完成1亿元融资，加速PD-1上市 2020-12-28
• Cullinan Oncology Completes $131.2 Million Series C Financing 2020-12-17
• Vivace Therapeutics Announces $30 Million Series C Financing to Fund Clinical Programs Targeting the Hippo Pathway 2020-12-16
• IGM Announces Closing of $230 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares 2020-12-12
• AbCellera Announces Pricing of Initial Public Offering 2020-12-11
• 勃林格殷格翰拟11.8亿欧元收购NBE-Therapeutics，加强ADC药物开发战略 2020-12-10
• XOMA Announces Offering of Series A Cumulative Perpetual Preferred Stock 2020-12-10
• IGM Announces Proposed Public Offering 2020-12-08

登录医药魔方官网 查看更多资讯